AI-powered drug hunters are approaching a pivotal stage in their evolution

Efforts to use AI for drug discovery have been underway for about a decade, but industry watchers expect an inflection point to be approaching for investors, who have been looking for ways to determine how drug developers evaluate AI. Artificial intelligence and machine learning offer the potential to accelerate the search for new treatments by … Read more